Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Delaware 68-0454536 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File N ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Jody Cain ??? Investor Relations-LHA Justin Hall ??? President and Chief Executive Officer Andy Jones ??? Chief Financial Officer Conference Call Participants Jeffrey Cohen ??? Ladenburg Thalmann Ed Woo ??? Ascendiant Capital Operator Welcome to the NovaBay Pharmaceuticals Fourth Quarter 2020 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Inst ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33678 NOVABAY PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 68-0454536 (Sta ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ET Company Participants Jody Cain - VP, LHA Justin Hall - President & CEO Andrew Jones - CFO & Treasurer Conference Call Participants Edward Woo - Ascendiant Capital Operator Welcome to the NovaBay Pharmaceuticals Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we'll hold a Q&A session. [Operator Instructions] As a reminder, this conference i ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Delaware 68-0454536 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) For the transition period from to 2000 Powell Street, Suite 1150, Emeryville, CA 94608 (Address of principal executive offices) (Zip Code) Co ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Yvonne Briggs - Vice President, LHA Justin Hall - President & Chief Executive Officer Andrew Jones - Chief Financial Officer & Treasurer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Welcome to the NovaBay Pharmaceuticals Conference Call. At this time all participants are in a listen-only mode. Following management's prepared remarks we'll hold a Q&A session. [O ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33678 NOVABAY PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 68-0454536 ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Yvonne Briggs - Vice President, LHA Justin Hall - President and Chief Executive Officer Andrew Jones - Chief Financial Officer and Treasurer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Edward Woo - Ascendiant Capital Markets, LLC Operator Welcome to the NovaBay Pharmaceuticals Conference Call. At this time, all participants are in a listen-only mode. Following management? ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33678 NOVABAY PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 68-0454536 (State or other ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Q4 2019 Earnings Conference Call March 26, 2020 4:30 PM ET Company Participants Jody Cain - IR Justin Hall - President and CEO Jason Raleigh - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Edward Woo - Ascendiant Capital Operator Welcome to the NovaBay Pharmaceuticals 2019 Fourth Quarter and Full Years' Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we'll hold a Q&A se ...